Brian Brenegan

Brian Brenegan has an extensive background in operational management, strategic planning, and sales channel management, with over 28 years of experience at Mortara Instrument in various roles.

After the acquisition of Mortara by Welch Allyn, Brian retired in April 2017 but later took on the role of CEO at Cardioline, an Italian ECG company, in October 2018, managing operations from Milwaukee and traveling to Italy monthly.

Following the sale of Cardioline to Archimed in November 2021, Brian transitioned from CEO to a consulting role, particularly focusing on business development in the US market.

Brian holds a BBA in Accounting from UW-Madison and the Wisconsin School of Business. Throughout his career, he has held key positions such as Director of Business Development, Chief Operating Officer, Senior Vice President, and Vice President Finance.